Structure–function insights reveal the human ribosome as a cancer target for antibiotics
The ribosome of bacteria and other unicellular pathogens is a common target for antibiotic drugs. Here the authors determine a structure of the human ribosome bound to the translation inhibitor cycloheximide, and provide evidence that targeting the ribosome is a promising avenue for cancer therapy.
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms12856 |
id |
doaj-5c015c0b3ce04e609d082a4c3d51b4f2 |
---|---|
record_format |
Article |
spelling |
doaj-5c015c0b3ce04e609d082a4c3d51b4f22021-05-11T11:05:29ZengNature Publishing GroupNature Communications2041-17232016-09-01711810.1038/ncomms12856Structure–function insights reveal the human ribosome as a cancer target for antibioticsAlexander G. Myasnikov0S. Kundhavai Natchiar1Marielle Nebout2Isabelle Hazemann3Véronique Imbert4Heena Khatter5Jean-François Peyron6Bruno P. Klaholz7Department of Integrated Structural Biology, Centre for Integrative Biology (CBI), IGBMC (Institute of Genetics and of Molecular and Cellular Biology)Department of Integrated Structural Biology, Centre for Integrative Biology (CBI), IGBMC (Institute of Genetics and of Molecular and Cellular Biology)INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M)Department of Integrated Structural Biology, Centre for Integrative Biology (CBI), IGBMC (Institute of Genetics and of Molecular and Cellular Biology)INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M)Department of Integrated Structural Biology, Centre for Integrative Biology (CBI), IGBMC (Institute of Genetics and of Molecular and Cellular Biology)INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M)Department of Integrated Structural Biology, Centre for Integrative Biology (CBI), IGBMC (Institute of Genetics and of Molecular and Cellular Biology)The ribosome of bacteria and other unicellular pathogens is a common target for antibiotic drugs. Here the authors determine a structure of the human ribosome bound to the translation inhibitor cycloheximide, and provide evidence that targeting the ribosome is a promising avenue for cancer therapy.https://doi.org/10.1038/ncomms12856 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexander G. Myasnikov S. Kundhavai Natchiar Marielle Nebout Isabelle Hazemann Véronique Imbert Heena Khatter Jean-François Peyron Bruno P. Klaholz |
spellingShingle |
Alexander G. Myasnikov S. Kundhavai Natchiar Marielle Nebout Isabelle Hazemann Véronique Imbert Heena Khatter Jean-François Peyron Bruno P. Klaholz Structure–function insights reveal the human ribosome as a cancer target for antibiotics Nature Communications |
author_facet |
Alexander G. Myasnikov S. Kundhavai Natchiar Marielle Nebout Isabelle Hazemann Véronique Imbert Heena Khatter Jean-François Peyron Bruno P. Klaholz |
author_sort |
Alexander G. Myasnikov |
title |
Structure–function insights reveal the human ribosome as a cancer target for antibiotics |
title_short |
Structure–function insights reveal the human ribosome as a cancer target for antibiotics |
title_full |
Structure–function insights reveal the human ribosome as a cancer target for antibiotics |
title_fullStr |
Structure–function insights reveal the human ribosome as a cancer target for antibiotics |
title_full_unstemmed |
Structure–function insights reveal the human ribosome as a cancer target for antibiotics |
title_sort |
structure–function insights reveal the human ribosome as a cancer target for antibiotics |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2016-09-01 |
description |
The ribosome of bacteria and other unicellular pathogens is a common target for antibiotic drugs. Here the authors determine a structure of the human ribosome bound to the translation inhibitor cycloheximide, and provide evidence that targeting the ribosome is a promising avenue for cancer therapy. |
url |
https://doi.org/10.1038/ncomms12856 |
work_keys_str_mv |
AT alexandergmyasnikov structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT skundhavainatchiar structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT mariellenebout structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT isabellehazemann structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT veroniqueimbert structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT heenakhatter structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT jeanfrancoispeyron structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics AT brunopklaholz structurefunctioninsightsrevealthehumanribosomeasacancertargetforantibiotics |
_version_ |
1721447056749363200 |